Pechous, R.D.; Malaviarachchi, P.A.; Xing, Z.; Douglas, A.; Crane, S.D.; Theriot, H.M.; Zhang, Z.; Ghaffarieh, A.; Huang, L.; Yu, Y.E.;
et al. SARS-CoV-2 Infection Causes Heightened Disease Severity and Mortality in a Mouse Model of Down Syndrome. Biomedicines 2024, 12, 543.
https://doi.org/10.3390/biomedicines12030543
AMA Style
Pechous RD, Malaviarachchi PA, Xing Z, Douglas A, Crane SD, Theriot HM, Zhang Z, Ghaffarieh A, Huang L, Yu YE,
et al. SARS-CoV-2 Infection Causes Heightened Disease Severity and Mortality in a Mouse Model of Down Syndrome. Biomedicines. 2024; 12(3):543.
https://doi.org/10.3390/biomedicines12030543
Chicago/Turabian Style
Pechous, Roger D., Priyangi A. Malaviarachchi, Zhuo Xing, Avrium Douglas, Samantha D. Crane, Hayley M. Theriot, Zijing Zhang, Alireza Ghaffarieh, Lu Huang, Y. Eugene Yu,
and et al. 2024. "SARS-CoV-2 Infection Causes Heightened Disease Severity and Mortality in a Mouse Model of Down Syndrome" Biomedicines 12, no. 3: 543.
https://doi.org/10.3390/biomedicines12030543
APA Style
Pechous, R. D., Malaviarachchi, P. A., Xing, Z., Douglas, A., Crane, S. D., Theriot, H. M., Zhang, Z., Ghaffarieh, A., Huang, L., Yu, Y. E., & Zhang, X.
(2024). SARS-CoV-2 Infection Causes Heightened Disease Severity and Mortality in a Mouse Model of Down Syndrome. Biomedicines, 12(3), 543.
https://doi.org/10.3390/biomedicines12030543